hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Serotonin syndromea rare but serious condition from excessive serotoninis extremely uncommon with semaglutide and Lexapro at typical doses, but symptoms include rapid heartbeat, muscle stiffness, confusion, or high fever
Tips for Getting Aetna to Cover Your GLP-1 Ask your doctor to use diagnosis codes for both obesity (E66.01) and any comorbidities Document every prior weight loss attempt in your medical records before submitting the PA If your employer plan excludes anti-obesity medications, ask your HR department whether they would consider adding coverage during the next benefits cycle Consider using the Wegovy savings card or Zepbound savings program to reduce your copay even further Always compare GLP-1 providers by total monthly cost at your maintenance dose, not the advertised starting price
These treatments can help to: Lower blood sugar by boosting insulin when you eat